Covered recipient · General Payments record
ABIOLA F IBRAHEEM
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2024
$4,410.04
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $644.62 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $410.91 | 5 |
| Eli Lilly and Company | $206.67 | 2 |
| Genentech USA, Inc. | $27.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $114.95 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104491250 | CMS |
| AstraZeneca Pharmaceuticals LP | $40.82 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105457712 | CMS |
| AstraZeneca Pharmaceuticals LP | $111.80 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105748987 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.43 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105641362 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.91 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104552674 | CMS |
| Eli Lilly and Company | $129.87 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136004823 | CMS |
| Eli Lilly and Company | $76.80 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136004191 | CMS |
| Genentech USA, Inc. | $27.04 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132971949 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.